Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (71-80 of 177) with videos related to

Pageof 18
Sort By:
Sao Paulo Medical Journal = Revista Paulista De Medicina|March 12, 2020
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic studyPedro Aguiar Júnior, Carmelia Maria Noia Barreto, Felipe Roitberg, et al.
Breast Cancer Research and Treatment|July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancerVakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Frontiers in Oncology|November 30, 2023
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedsideChris Montoya, Benjamin Spieler, Scott M Welford, et al.
JCO Global Oncology|November 19, 2025
Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health SystemGabriel Lenz, Rafael Alvim Pereira, Wallace Klein Schwengber, et al.
World Journal of Gastrointestinal Oncology|December 17, 2010
Severe colitis associated with docetaxel use: A report of four casesAndres F Carrion, Peter J Hosein, Eugene M Cooper, et al.
Frontiers in Immunology|December 31, 2025
Leveraging beneficial microbiome-immune interactions via probiotic use in cancer immunotherapyChinmay T Jani, Kyle Edwards, Charmi Bhanushali, et al.
JCO Oncology Practice|May 11, 2021
Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-AnalysisPhilippos A Costa, Eduardo E Saul, Yonette Paul, et al.
Clinical Rheumatology|March 27, 2004
Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literatureJulio A Chirinos, Leonardo J Tamariz, Gilberto Lopes, et al.
The Oncologist|November 18, 2018
<i>EGFR</i> Mutation Testing: Changing Patterns of Molecular Testing in BrazilSofia Palacio, Luciola Pontes, Edna Prado, et al.
Cancers|January 11, 2022
Validating an Instrument for Direct Patient Reporting of Distress and Chemotherapy-Related Toxicity among South African Cancer PatientsCharmaine L Blanchard, Keletso Mmoledi, Michael H Antoni, et al.
Pageof 18

Showing results (71-80 of 177) with videos related to

Sort By:
Pageof 18
Sao Paulo Medical Journal = Revista Paulista De Medicina|March 12, 2020
Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic studyPedro Aguiar Júnior, Carmelia Maria Noia Barreto, Felipe Roitberg, et al.
Breast Cancer Research and Treatment|July 12, 2014
Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancerVakaramoko Diaby, Georges Adunlin, Simon B Zeichner, et al.
Frontiers in Oncology|November 30, 2023
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedsideChris Montoya, Benjamin Spieler, Scott M Welford, et al.
JCO Global Oncology|November 19, 2025
Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health SystemGabriel Lenz, Rafael Alvim Pereira, Wallace Klein Schwengber, et al.
World Journal of Gastrointestinal Oncology|December 17, 2010
Severe colitis associated with docetaxel use: A report of four casesAndres F Carrion, Peter J Hosein, Eugene M Cooper, et al.
Frontiers in Immunology|December 31, 2025
Leveraging beneficial microbiome-immune interactions via probiotic use in cancer immunotherapyChinmay T Jani, Kyle Edwards, Charmi Bhanushali, et al.
JCO Oncology Practice|May 11, 2021
Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-AnalysisPhilippos A Costa, Eduardo E Saul, Yonette Paul, et al.
Clinical Rheumatology|March 27, 2004
Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literatureJulio A Chirinos, Leonardo J Tamariz, Gilberto Lopes, et al.
The Oncologist|November 18, 2018
<i>EGFR</i> Mutation Testing: Changing Patterns of Molecular Testing in BrazilSofia Palacio, Luciola Pontes, Edna Prado, et al.
Cancers|January 11, 2022
Validating an Instrument for Direct Patient Reporting of Distress and Chemotherapy-Related Toxicity among South African Cancer PatientsCharmaine L Blanchard, Keletso Mmoledi, Michael H Antoni, et al.
Pageof 18